(Photo: Miriam Doerr Martin Frommherz/Shutterstock)

The Family and Medical Leave Act (FMLA) will continue to apply to some employees who seek treatment through telemedicine. Guidance from the U.S. Department of Labor in late December confirmed that its temporary policy will be extended for the foreseeable future.

FMLA offers eligible employees the opportunity to take up to 12 weeks of protected unpaid leave from work (and perhaps more) in certain situations. Two of the most common ways that these workers can receive FMLA leave is for their own serious health condition or caring for certain family members with serious health conditions of their own. Eligible individuals can demonstrate they have a serious health condition under the statute and its regulations by showing they have received subsequent treatment after a stint of inpatient care or they are receiving continuing treatment from a health-care provider.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.